PPHM Stock Updates 08/25/2014 08:21:15 $PPHM
One curiosity Carboat, you recently showed back up here announcing a long position because you like the "pot odds" for PPHM. Yet you believe we will not know success/failure for a few years still. What brought you in so far in advance of the decision date?
Has anyone found any correlation between Berlin or Tradegate prices and early trading here in PPHM.
PPHM Stock Message Board http://investorshangout.com/Peregrine-Pharmac...PHM-55152/
It is all about the bid.
What insight?
Incredible PPHM knowledge?
Notice the ?
8am came and went again with no news so another weekend of fantasies go to the wayside. The good news is that the 2009 newbie update list does not need to be updated with a BAVI and/or Cotara partnership. There is always tomorrow.
See iHub's MostRead, MostPosted, Breakout Boards. & TickerBuzzCloud.
Access via "Hot" Button at top of iHub Page.
PPHM is currently #1 Most Read Board
In Top Seven Most Posted, which includes 4 non-stock boards
Number 15 on Possible BreakOuts
And green on the Ticker Buzz Cloud
Could be an exciting time period to be a stockholder!
GLTA Real Stockholders, Employees, Patients, and Their Families!
Bioharm,what if we partner with Bayer for liver and later bavi is found to be effective with another drug for liver, maybe one of Roche's and that too in cts has a comparable SOC with Sor/Bavi? What then? Nice dreaming, isn't it instead of millennium of pps straight as an horizontal arrow across our charts.
St. Peregrine "The patron saint of cancer patients"
I believe St. Peregrine is in our back splash photo on the Sunrise site.
thanks jim on the road as usual
wook
At Avid, a wholly owned subsidiary of Eli Lilly and Company
http://www.avidrp.com/
4us.....I found the "radio labeling" under the Avid part in the link interesting. But that's not our Avid....or is it?????
Note....we were JUST talking about radio labeling in last week.
Coincidence??????
wook
Looks like very interesting times ahead... GLTA!
Top O the Morning Peregooglers!!!!!
Keep up the great work 4us et al!!!!
Maybe it's a Monday but I'll take any day that ends in a Y!
Will the rubber peel out or pop?????
Time will tell as the world turns.
Best of Luck and Data.
wook
I'm waiting........
Quote:
For example, Warner Chilcott was purchased by Actavis last year, so why would Bayer still be partnering with them?
IFU.... you may also ask why would Bayer/Onyx be partnered if Amgen bought out Onyx, just because someone gets bought out... all their prior partnerships do not become null and void and there are many links that bring Bayer and Peregrine side by side, including Dr. Adam Yopp and the current Bavi+Sorafenib trial...
Aug 26, 2013 --- Amgen to buy Onyx for $10.4 Billion
http://www.bloomberg.com/news/2013-08-25/amge...llion.html
Current: Onyx / Bayer partner status...
Partner Status
Onyx and Bayer develop and market Nexavar under collaboration and co-promotion agreements. According to these agreements, Onyx and Bayer each fund 50 percent of the development costs for Nexavar worldwide, excluding Japan, where Bayer funds all product development. Onyx and Bayer co-promote Nexavar in the U.S. and share equally in any profits or losses. Outside of the U.S., Bayer has exclusive marketing rights and Onyx and Bayer share profits 50/50 globally, excluding Japan, where Bayer paid Onyx a one-time payment of $160 million in 2011, as part of its expanded collaboration agreement.
http://www.onyx.com/therapies/nexavar-sorafenib-tablets
Aug 30, 2013
Of course, Bayer's partner will soon be Amgen ($AMGN), which this week nailed down its $10.4 billion deal to buy Onyx. Amgen saw the promise in Onyx' innovative cancer drugs, like Kyprolis, the multiple myeloma drug that was seen as a linchpin to the deal and one believed by analysts to have huge potential. Launched last summer, Kyprolis brought in $64 million by year's end, and by the end of the second quarter this year, it had racked up another $125 million. Analysts have forecast it to hit $2 billion to $2.4 billion in sales by 2019. That is the kind of quick growth Amgen wants to see as its biggest-selling drugs are threatened by new competition from biosimilars.
http://www.fiercepharma.com/story/bayer-onyx-...2013-08-30
So its important to note, even though we all see Bayer/Onyx ..... and since Amgen owns Onyx... I'd speculate Amgen had a very good strategic reason to spend upwards of $10.4 Billion for Onyx at $125 pps, as the Bavi pipeline may be worth well north of that price when everyone sees the true depth, within Peregrines pipeline
What about the fact Page Updated 2ndQuarter2014...
and the reference to "Stockholders"???
TIA & GLTA!
4OurRetirement Sunday, 08/24/14 11:45:03 PM
Re: Big/Rich post# 187526
One curiosity Carboat, you recently showed back up here announcing a long position because you like the "pot odds" for PPHM. Yet you believe we will not know success/failure for a few years still. What brought you in so far in advance of the decision date?
Has anyone found any correlation between Berlin or Tradegate prices and early trading here in PPHM.
PPHM Stock Message Board http://investorshangout.com/Peregrine-Pharmac...PHM-55152/
It is all about the bid.
What insight?
Incredible PPHM knowledge?
Notice the ?
8am came and went again with no news so another weekend of fantasies go to the wayside. The good news is that the 2009 newbie update list does not need to be updated with a BAVI and/or Cotara partnership. There is always tomorrow.
See iHub's MostRead, MostPosted, Breakout Boards. & TickerBuzzCloud.
Access via "Hot" Button at top of iHub Page.
PPHM is currently #1 Most Read Board
In Top Seven Most Posted, which includes 4 non-stock boards
Number 15 on Possible BreakOuts
And green on the Ticker Buzz Cloud
Could be an exciting time period to be a stockholder!
GLTA Real Stockholders, Employees, Patients, and Their Families!
Bioharm,what if we partner with Bayer for liver and later bavi is found to be effective with another drug for liver, maybe one of Roche's and that too in cts has a comparable SOC with Sor/Bavi? What then? Nice dreaming, isn't it instead of millennium of pps straight as an horizontal arrow across our charts.
St. Peregrine "The patron saint of cancer patients"
I believe St. Peregrine is in our back splash photo on the Sunrise site.
thanks jim on the road as usual
wook
At Avid, a wholly owned subsidiary of Eli Lilly and Company
http://www.avidrp.com/
4us.....I found the "radio labeling" under the Avid part in the link interesting. But that's not our Avid....or is it?????
Note....we were JUST talking about radio labeling in last week.
Coincidence??????
wook
Looks like very interesting times ahead... GLTA!
Top O the Morning Peregooglers!!!!!
Keep up the great work 4us et al!!!!
Maybe it's a Monday but I'll take any day that ends in a Y!
Will the rubber peel out or pop?????
Time will tell as the world turns.
Best of Luck and Data.
wook
I'm waiting........
Quote:
For example, Warner Chilcott was purchased by Actavis last year, so why would Bayer still be partnering with them?
IFU.... you may also ask why would Bayer/Onyx be partnered if Amgen bought out Onyx, just because someone gets bought out... all their prior partnerships do not become null and void and there are many links that bring Bayer and Peregrine side by side, including Dr. Adam Yopp and the current Bavi+Sorafenib trial...
Aug 26, 2013 --- Amgen to buy Onyx for $10.4 Billion
http://www.bloomberg.com/news/2013-08-25/amge...llion.html
Current: Onyx / Bayer partner status...
Partner Status
Onyx and Bayer develop and market Nexavar under collaboration and co-promotion agreements. According to these agreements, Onyx and Bayer each fund 50 percent of the development costs for Nexavar worldwide, excluding Japan, where Bayer funds all product development. Onyx and Bayer co-promote Nexavar in the U.S. and share equally in any profits or losses. Outside of the U.S., Bayer has exclusive marketing rights and Onyx and Bayer share profits 50/50 globally, excluding Japan, where Bayer paid Onyx a one-time payment of $160 million in 2011, as part of its expanded collaboration agreement.
http://www.onyx.com/therapies/nexavar-sorafenib-tablets
Aug 30, 2013
Of course, Bayer's partner will soon be Amgen ($AMGN), which this week nailed down its $10.4 billion deal to buy Onyx. Amgen saw the promise in Onyx' innovative cancer drugs, like Kyprolis, the multiple myeloma drug that was seen as a linchpin to the deal and one believed by analysts to have huge potential. Launched last summer, Kyprolis brought in $64 million by year's end, and by the end of the second quarter this year, it had racked up another $125 million. Analysts have forecast it to hit $2 billion to $2.4 billion in sales by 2019. That is the kind of quick growth Amgen wants to see as its biggest-selling drugs are threatened by new competition from biosimilars.
http://www.fiercepharma.com/story/bayer-onyx-...2013-08-30
So its important to note, even though we all see Bayer/Onyx ..... and since Amgen owns Onyx... I'd speculate Amgen had a very good strategic reason to spend upwards of $10.4 Billion for Onyx at $125 pps, as the Bavi pipeline may be worth well north of that price when everyone sees the true depth, within Peregrines pipeline
What about the fact Page Updated 2ndQuarter2014...
and the reference to "Stockholders"???
TIA & GLTA!
4OurRetirement Sunday, 08/24/14 11:45:03 PM
Re: Big/Rich post# 187526
